More than 10% of people taking<unk>  have headaches or fatigue; rashes, nausea, diarrhea, and insomnia occur in between 1% and 10% of people taking it. More severe reactions are connected with allergic reactions to the medications and cardiovascular problems. Harvoni side effects are considered relatively mild compared to older interferon-based treatment.<unk>  could cause hepatitis B re-activation in people co-infected with hepatitis B and C viruses. The European Medicines Agency recommended screening all people for hepatitis B before starting<unk>  for hepatitis C in order to minimize the risk of hepatitis B reactivation.
Ledipasvir/sofosbuvir
Atazanavir/ritonavir
Sofosbuvir/velpatasvir
Abacavir/lamivudine
Baloxavir marboxil
Atazanavir/cobicistat
Lamivudine/tenofovir
Fosamprenavir